Baker Bros. Advisors Lp Incyte Corp (INCY) insider trading activity

BAKER BROS. ADVISORS LP Transaction History

Date	Transaction	Value	Shares Traded
Feb 11 2022	BUY Open market or private purchase	$18,492,787 $66.88 p/Share	276,507
Feb 10 2022	BUY Open market or private purchase	$54,955,905 $67.1 p/Share	819,015
Dec 31 2021	BUY Grant, award, or other acquisition	-	838
Dec 17 2021	BUY Open market or private purchase	$78,366,513 $72.84 p/Share	1,075,872
Dec 16 2021	BUY Open market or private purchase	$12,187,294 $71.98 p/Share	169,315
Dec 15 2021	BUY Open market or private purchase	$24,477,698 $69.87 p/Share	350,332
Sep 30 2021	BUY Grant, award, or other acquisition	-	786
Jun 30 2021	BUY Grant, award, or other acquisition	-	690
May 26 2021	BUY Grant, award, or other acquisition	-	3,846
May 14 2021	BUY Exercise of conversion of derivative security	$758,800 $18.97 p/Share	40,000
Mar 31 2021	BUY Grant, award, or other acquisition	-	728
Dec 31 2020	BUY Grant, award, or other acquisition	-	686
Sep 30 2020	BUY Grant, award, or other acquisition	-	634
Jun 30 2020	BUY Grant, award, or other acquisition	-	588
May 28 2020	BUY Open market or private purchase	$205 $102.55 p/Share	2
May 26 2020	BUY Grant, award, or other acquisition	-	2,564
Apr 28 2020	BUY Exercise of conversion of derivative security	$533,600 $13.34 p/Share	40,000
Mar 31 2020	BUY Grant, award, or other acquisition	$57,412 $73.23 p/Share	784
Dec 31 2019	BUY Grant, award, or other acquisition	$55,186 $87.32 p/Share	632
Sep 30 2019	BUY Grant, award, or other acquisition	$54,039 $74.23 p/Share	728
Jun 28 2019	BUY Grant, award, or other acquisition	$52,675 $84.96 p/Share	620
Jun 06 2019	SELL Other acquisition or disposition	-	2,295,944
Apr 26 2019	BUY Grant, award, or other acquisition	-	4,560
Mar 29 2019	BUY Grant, award, or other acquisition	$56,767 $86.01 p/Share	660
Feb 26 2019	BUY Exercise of conversion of derivative security	$112,000 $2.8 p/Share	40,000

Also insider at

GHDX

GENOMIC HEALTH INC

Director

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

> 10% Shareholder

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

BGNE

BeiGene, Ltd. Healthcare

ACAD

ACADIA PHARMACEUTICALS INC Healthcare

MRTX

Mirati Therapeutics, Inc. Healthcare

BLCM

BELLICUM PHARMACEUTICALS, INC Healthcare

> 10% Shareholder

SGEN

Seagen Inc. Healthcare

Director

NVTA

Invitae Corp Healthcare

> 10% Shareholder

ALXN

ALEXION PHARMACEUTICALS, INC.

Director

NLTX

Neoleukin Therapeutics, Inc. Healthcare

Director

KNSA

Kiniksa Pharmaceuticals, Ltd. Healthcare

KOD

Kodiak Sciences Inc. Healthcare

HOOK

HOOKIPA Pharma Inc. Healthcare

BCEL

Atreca, Inc. Healthcare

IGMS

IGM Biosciences, Inc. Healthcare

ZYME

Zymeworks Inc. Healthcare

Director

PRLD

Prelude Therapeutics Inc Healthcare

TLIS

Talis Biomedical Corp Healthcare

Director

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

Director

TCRX

TScan Therapeutics, Inc. Healthcare

TRDA

Entrada Therapeutics, Inc. Healthcare

DBVT

DBV Technologies S.A. Healthcare

Director

MDGL

MADRIGAL PHARMACEUTICALS, INC. Healthcare

VTVT

vTv Therapeutics Inc. Healthcare

KYMR

Kymera Therapeutics, Inc. Healthcare

BCYC

BICYCLE THERAPEUTICS plc Healthcare

IMCR

Immunocore Holdings plc Healthcare

BBA